Clinical trial
A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the…
NCT00377039 · Sosei, Industry · Completed
Key facts
| NCT number | NCT00377039 |
|---|---|
| Title | A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia |
| Official title | A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects. |
| Lead sponsor | Sosei, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | AD 337 |
| Enrollment | 100 |
| Start date | Aug 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Sep 15, 2006 |
| Last update posted | Oct 2, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: